Surrogate gene therapy for muscular dystrophy
An engineered truncated gene derived from the dystrophin-related protein (utrophin), prevents pathology without an immune response in an animal model of Duchenne muscular dystrophy (DMD) gene therapy.
Үндсэн зохиолчид: | Davies, KE, Chamberlain, JS |
---|---|
Формат: | Journal article |
Хэл сонгох: | English |
Хэвлэсэн: |
Springer Nature
2019
|
Ижил төстэй зүйлс
-
Therapeutic approaches to muscular dystrophy.
-н: Goyenvalle, A, зэрэг
Хэвлэсэн: (2011) -
The Pathogenesis and Therapy of Muscular Dystrophies
-н: Guiraud, S, зэрэг
Хэвлэсэн: (2015) -
Progress in therapy for Duchenne muscular dystrophy.
-н: Fairclough, R, зэрэг
Хэвлэсэн: (2011) -
Progress in therapy for Duchenne muscular dystrophy
-н: Fairclough, R, зэрэг
Хэвлэсэн: (2011) -
Utrophin in the therapy of Duchenne Muscular Dystrophy
-н: Potter, A, зэрэг
Хэвлэсэн: (2006)